KAYLA DONALDSON: Open Payments
NPI 1295329274 · HAMMOND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$519 in 19 payments from 10 companies in 2025. Trend: 2023 $89 · 2024 $192 · 2025 $519
Food & beverage: $451Education: $68
| Company | Payments | Amount |
|---|---|---|
| BETA BIONICS, INC. | 3 | $161 |
| Novo Nordisk Inc | 5 | $105 |
| Astellas Pharma US Inc | 2 | $88 |
| Verona Pharma, Inc. | 2 | $45 |
| Lilly USA, LLC | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| SANOFI-AVENTIS U.S. LLC | 1 | $19 |
| Amgen Inc. | 1 | $15 |
| SHIELD THERAPEUTICS INC | 1 | $14 |
| ABBVIE INC. | 1 | $14 |
Products named: iLet Bionic Pancreas, Ohtuvayre, Ozempic, Rybelsus, MOUNJARO, ICLUSIG, Veozah, Wegovy.
Industry payments across LA — which companies pay providers there.
